Trial Details
Not RecruitingBasic Information
| Clinical ID | c5126 |
|---|---|
| Identifier | EUCTR2009-018085-35-DK |
| Trial Title | Intestinal Inflammation in Ankylosing Spondylitis assessed by Fecal Calprotectin, Capsular Endoscopy and Colonoscopy and the effects of Adalimumab on mucosal healing - INTASAH |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Ankylosing spondylitis Inflammatory bowel disease MedDRA version: 14.0.Level: PT.Classification code 10061371.Term: Spondylitis.System Organ Class: 10028395 - Musculoskeletal and connective tissue disord |
| Interventions | Trade Name: HumiraPharmaceutical Form: Solution for injectionINN or Proposed INN: ADALIMUMABCAS Number: 331731-18-1Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 40- |
Participant Information
| Sponsor | Regionalhospital Silkeborg |
|---|---|
| City | NULL |
| Country/Region | Denmark |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |